Cyclo [Arg-Gly-Asp-D-Phe-Val] structure
|
Common Name | Cyclo [Arg-Gly-Asp-D-Phe-Val] | ||
---|---|---|---|---|
CAS Number | 137813-35-5 | Molecular Weight | 574.62900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H38N8O7 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Cyclo [Arg-Gly-Asp-D-Phe-Val]Cyclo(Arg-Gly-Asp-D-Phe-Val) is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) can be used for the research of acute myeloid leukemia[1]. |
Name | cyclo(arg-gly-asp-d-phe-val) |
---|---|
Synonym | More Synonyms |
Description | Cyclo(Arg-Gly-Asp-D-Phe-Val) is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) can be used for the research of acute myeloid leukemia[1]. |
---|---|
Related Catalog | |
Target |
αvβ3[1] |
In Vitro | Cyclo(Arg-Gly-Asp-d-Phe-Val) (c(RGDfV)) (35 nM, 4-24 h) disruptes the adhesion and migration between the tumor cells and the matrix, induces the leukemia cells to leave the protective microenvironment and increases their sensitivity to cell cycle-dependent agents[1]. Cell Cycle Analysis[1] Cell Line: MV4–11 cells Concentration: 35 nM Incubation Time: 24 h Result: Affected the leukemia cell cycle, decreased the G0/G1 phase of leukemia cells in the 3D and 2D culture systems and increased the S phase of leukemia cells in the 3D and 2D culture systems. Apoptosis Analysis[1] Cell Line: MV4–11 cells Concentration: 35 nM Incubation Time: 24 h Result: Increased the apoptosis rates. |
Molecular Formula | C26H38N8O7 |
---|---|
Molecular Weight | 574.62900 |
Exact Mass | 574.28600 |
PSA | 244.70000 |
LogP | 0.52700 |
RGDFV PEPTIDE,CYCLIC |
Cyclo(Arg-Gly-Asp-D-Phe-Val) |